Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ClonDoTrial: clonidine and doxazosin for nightmares in posttraumatic stress disorder
2021-000319-21Phase 2Active
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in post-traumatic stress disorder (PTSD) comparing Clonidine, Doxazosin and Placebo (3 arms). Started Jul 2021; status: active.
02
Drugs
clonidinedoxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on 2021-000319-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000319-21.